Not that Merck was the only company selling COX-2specific inhibitors.
Pfizer withdrew Bextra, a similar drug, in 2005 and last year agreed to pay $2.3 billion for fraudulent marketing of Bextra, Lyrica and two other drugs which was the largest criminal fine ever imposed in the US. Patients taking Bextra after heart surgery were 2.19 times more likely to suffer a stroke or heart attack said American Heart Association information.
Only five years earlier, Pfizer, a repeat offender, agreed to pay $430 million for abuses pertaining to seizure drug Neurontin and seven years before that, agreed to pay $49 million to settle charges it defrauded Medicaid by overcharging for cholesterol drug Lipitor.
Pfizer still manufacturers the COX-2 specific inhibitor Celebrex though it is also linked to life-threatening side effects included the case of Timothy Moorley, an outspoken patient in a class action suit against Pfizer in Canada, which is receiving wide publicity.
Though Vioxx and Bextra are gone and Celebrex is under a darkening cloud, the practice of prescribing unsafe drugs for simple pain that can just as easily be treated with older and over-the-counter drugs is alive and well.
FDA linked Lyrica and other seizure drugs to suicide in 2008 and mandated warnings, but Lyrica is widely prescribed off label in civilian and military contexts for pain and migraine -- no doubt from the marketing abuses Pfizer acknowledges in last year's settlement.
When Lyrica was first faced with a black box suicide warning, Pfizer sent FDA a 92-page appeal calling suicide statistics "an exaggeration of risk" that could "overwarn" patients and prescribers and make them "underestimate the risks of declining treatment." Especially revenue risks.
Lyrica, so similar to the deadly drug Neurontin it is called Son of Neurontin, is linked to memory loss, mental confusion, extreme weight gain, hair loss, impaired driving, disorientation, twitching and at least two deaths on the drug rating site askapatient.
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).